BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10826461)

  • 1. Medical therapy, symptoms, and the distress the cause: relation to quality of life in patients with angina pectoris and/or hypertension.
    Hollenberg NK; Williams GH; Anderson R
    Arch Intern Med; 2000 May; 160(10):1477-83. PubMed ID: 10826461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life and calcium channel blockade with nifedipine GITS versus amlodipine in hypertensive patients in Spain. Gastrointestinal Therapeutic System.
    Testa MA; Turner RR; Simonson DC; Krafcik MB; Calvo C; Luque-Otero M
    J Hypertens; 1998 Dec; 16(12 Pt 1):1839-47. PubMed ID: 9869019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical Symptoms Distress Index: a sensitive tool to evaluate the impact of pharmacological agents on quality of life.
    Anderson RB; Hollenberg NK; Williams GH
    Arch Intern Med; 1999 Apr; 159(7):693-700. PubMed ID: 10218748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris.
    Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD
    Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monotherapy with amlodipine or atenolol versus their combination in stable angina pectoris.
    Pehrsson SK; Ringqvist I; Ekdahl S; Karlson BW; Ulvenstam G; Persson S
    Clin Cardiol; 2000 Oct; 23(10):763-70. PubMed ID: 11061055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptoms and the distress they cause: comparison of an aldosterone antagonist and a calcium channel blocking agent in patients with systolic hypertension.
    Hollenberg NK; Williams GH; Anderson R; Akhras KS; Bittman RM; Krause SL
    Arch Intern Med; 2003 Jul; 163(13):1543-8. PubMed ID: 12860576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ivabradine: new drug. Best avoided in stable angina.
    Prescrire Int; 2007 Apr; 16(88):53-6. PubMed ID: 17458043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of metoprolol vs verapamil in patients with stable angina pectoris. The Angina Prognosis Study in Stockholm (APSIS).
    Rehnqvist N; Hjemdahl P; Billing E; Björkander I; Eriksson SV; Forslund L; Held C; Näsman P; Wallén NH
    Eur Heart J; 1996 Jan; 17(1):76-81. PubMed ID: 8682134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
    Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
    Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of long-acting dihydropyridine calcium channel blockers in hypertensive patients.
    Kloner RA; Vetrovec GW; Materson BJ; Levenstein M
    Am J Cardiol; 1998 Jan; 81(2):163-9. PubMed ID: 9591899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified-release nifedipine: a review of the use of modified-release formulations in the treatment of hypertension and angina pectoris.
    Croom KF; Wellington K
    Drugs; 2006; 66(4):497-528. PubMed ID: 16597165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circadian heart rate response to chronotherapy versus conventional therapy in patients with hypertension and myocardial ischemia.
    Glasser SP; Frishman W; White WB; Stone P; Johnson MF
    Clin Cardiol; 2000 Jul; 23(7):524-9. PubMed ID: 10894441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total Ischaemic Burden European Trial (TIBET). Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina. The TIBET Study Group.
    Dargie HJ; Ford I; Fox KM
    Eur Heart J; 1996 Jan; 17(1):104-12. PubMed ID: 8682116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atenolol/nifedipine combination: efficacy and tolerability of low dose synergistic bitherapy in the treatment of arterial hypertension].
    Krivitzky A; Nguyen G; Gaudouen Y; Legrand M; Cohen R
    Drugs; 1998; 56 Suppl 2():31-43. PubMed ID: 9813740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Total Ischaemic Burden European Trial (TIBET). Effects of atenolol, nifedipine SR and their combination on the exercise test and the total ischaemic burden in 608 patients with stable angina. The TIBET Study Group.
    Fox KM; Mulcahy D; Findlay I; Ford I; Dargie HJ
    Eur Heart J; 1996 Jan; 17(1):96-103. PubMed ID: 8682138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacology and clinical use of a fixed combination of nifedipine and slow release atenolol (Niften) in the treatment of arterial hypertension and angina pectoris].
    Verdecchia P
    Minerva Cardioangiol; 1993 Sep; 41(9):349-63. PubMed ID: 7903118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 6-week double-blind comparison of amlodipine and placebo in patients with stable exertional angina pectoris receiving concomitant beta-blocker therapy.
    Klein W; Mitrovic V; Neuss H; Schlepper M; Cocco G; Prager G; Fitscha P; Meisner W
    J Cardiovasc Pharmacol; 1991; 17 Suppl 1():S50-2. PubMed ID: 16296710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium-channel blockers for combined angina pectoris and systemic hypertension.
    Frishman WH; Charlap S; Kimmel B; Goldberger J; Phillippides G; Klein N
    Am J Cardiol; 1986 Feb; 57(7):22D-29D. PubMed ID: 3513513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.